Table 2.
Receiver operation characteristic curve analysis of parameters for the diagnosis of critical COVID-19 patients.
Critical.
| Parameters | AUC | P | 95% CI | Cut-off value | Jordan index | Sensitivity | Specificity |
|---|---|---|---|---|---|---|---|
| Lymphocytes | 0.865 | 0.0016 | 0.732–0.998 | <1060.00 | 0.604 | 77.78% | 82.61% |
| CD3+T | 0.826 | 0.0047 | 0.657–0.995 | <609.50 | 0.604 | 77.78% | 82.61% |
| CD8+T | 0.787 | 0.0126 | 0.620–0.955 | <227.50 | 0.517 | 77.78% | 73.91% |
| NK | 0.913 | 0.0003 | 0.790–1.000 | <66.50 | 0.778 | 77.78% | 100.00% |
| GrB + CD8 + T | 0.652 | 0.1867 | 0.427–0.878 | >76.5 | 0.382 | 55.56% | 82.61% |
| Perforin + CD8 + T | 0.652 | 0.1867 | 0.420–0.884 | >62.6 | 0.425 | 55.56% | 86.96 |
| GrA + NK | 0.826 | 0.0047 | 0.654–0.999 | <49.80 | 0.580 | 66.67% | 91.30% |
| Perforin + NK | 0.657 | 0.1731 | 0.457–0.857 | <80.5% | 0.314 | 44.44% | 86.96% |
AUC, area under the curve; 95% CI, 95% confidence interval.